罗欣药业：拟定增募资不超8.42亿元 用于创新药研发等项目

Group 1 - The core point of the article is that Luoxin Pharmaceutical (002793) plans to issue A-shares to specific investors, aiming to raise no more than 842 million yuan, which will be used for various projects including innovative drug research and development, raw material drug expansion and transformation, and to supplement working capital [1] Group 2 - The total amount to be raised from the issuance is capped at 842 million yuan, including the principal amount [1] - The funds will be allocated to three main areas: innovative drug R&D projects, the expansion and technical transformation of raw material drug production, and to enhance the company's liquidity [1]